Tel:
+49 (0)241 95 163 153
Fax:
+49 (0)241 95 163 155
E-Mail:
orders@anticorps-enligne.fr

Kallikrein 13 anticorps (AA 19-262)

KLK13 Reactivité: Humain WB, IP, ELISA, Neut Hôte: Chèvre Polyclonal unconjugated
N° du produit ABIN292875
  • Antigène Voir toutes Kallikrein 13 (KLK13) Anticorps
    Kallikrein 13 (KLK13) (Kallikrein-Related Peptidase 13 (KLK13))
    Épitope
    • 15
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    AA 19-262
    Reactivité
    • 30
    • 4
    • 4
    • 4
    • 3
    • 3
    • 3
    Humain
    Hôte
    • 25
    • 5
    • 1
    Chèvre
    Clonalité
    • 27
    • 4
    Polyclonal
    Conjugué
    • 16
    • 2
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    Cet anticorp Kallikrein 13 est non-conjugé
    Application
    • 30
    • 13
    • 13
    • 6
    • 5
    • 4
    • 3
    • 3
    • 2
    • 2
    • 1
    • 1
    Western Blotting (WB), Immunoprecipitation (IP), ELISA, Neutralization (Neut)
    Specificité
    Selected for its ability to recognize human KLK13 in direct ELISAs and Western Blots. In these formats, this antibody shows ~10 % cross-reactivity with rhKallikrein 8, and less than 5 % cross-reactivity with rhKallikrein 11, rhKallikrein 14, and rhKallikrein 15.
    Purification
    Affinity purified
    Immunogène
    NS0-derived rhKLK13 (aa19-262).
    Isotype
    IgG
    Top Product
    Discover our top product KLK13 Anticorps primaire
  • Indications d'application
    Approved: ELISA, IP, Neut, WB

    Usage: Western Blot: This antibody can be used at 0.1-0.2 μg/mL with the appropriate secondary reagents to detect human KLK13. The detection limit for rhKLK13 is approximately 5 ng/lane under non-reducing and reducing conditions. Immunoprecipitation: This antibody has been used to immunoprecipitate rhKLK13 from conditioned media of transfected NS0 cells. The recovered rhKLK13 can be detected by western blot analysis using a monoclonal antibody. Neutralization: This antibody was used to inhibit/neutralize the enzymatic activity of rhKLK13. The antibody was preincubated with the enzyme at different molar ratios at room temperature for 30 minutes. The enzyme was then assayed with a fluorogenic peptide substrate, Boc-VPR-AMC. 50 % of the proteolytic activity was inhibited by the antibody at approximately 8.6 μg/mL (IC50) under conditions in which the enzyme was present at 1 μg/mL and the substrate concentration was 100 M. Considering the molecular masses of the enzyme (28 kD) and the antibody (150 kD), IC50 was achieved at approximately 2:1 Molar ratio of the antibody to the enzyme. Direct ELISA: This antibody can be used at 0.5-1.0 μg/mL with the appropriate secondary reagents to detect human KLK13. The detection limit for rhKLK13 is approximately 1.0 ng/well.
    Commentaires

    Target Species of Antibody: Human

    Restrictions
    For Research Use only
  • Format
    Lyophilized
    Reconstitution
    deionized water
    Concentration
    Lot specific
    Buffer
    Lyophilized.
  • Antigène
    Kallikrein 13 (KLK13) (Kallikrein-Related Peptidase 13 (KLK13))
    Autre désignation
    KLK13 / Kallikrein 13 (KLK13 Produits)
    Synonymes
    anticorps KLK-L4, anticorps KLKL4, anticorps Egfbp-2, anticorps mGk-13, anticorps kallikrein related peptidase 13, anticorps kallikrein related-peptidase 13, anticorps KLK13, anticorps Klk13
    Sujet
    Name/Gene ID: KLK13
    Subfamily: Serine S1
    Family: Protease

    Synonyms: KLK13, Kallikrein 13, Kallikrein-13, KLK-L4, KLKL4, Kallikrein-like protein 4, Kallikrein-like gene 4
    ID gène
    26085
    UniProt
    Q9UKR3
    Pathways
    Système du Complément
Vous êtes ici:
Support technique